| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |